Oncology Impact Private Investment Fund 2, L.P. — SEC Form 4 filings

SEC reporting owner CIK 2104306. 1 Form 4 filing on record with FilingPulse; latest filed 2026-01-14.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2026-01-14 to 2026-01-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aktis Oncology, Inc. (AKTS)10% owner11 leg · 1,112,777 sh · $20,029,9866

Form 4 filings — Oncology Impact Private Investment Fund 2, L.P.

FiledFormIssuerReported transactionsSource
2026-01-144Aktis Oncology, Inc. (AKTS)
jointly with GADICKE ANSBERT, MPM ASSET MANAGEMENT LLC
Conversion (C): 1,314,262 · Conversion (C): 5,914,197 · Conversion (C): 1,577,119 · Purchase (P): 1,112,777 @ $18 · Conversion (C): 5,000,000 (derivative) @ $0 · Conversion (C): 22,500,000 (derivative) @ $0 · +1 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2104306 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →